We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and ... Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications. Show more
Illumina's planned divestment of GRAIL approved by the European Commission PR Newswire SAN DIEGO, April 12, 2024 SAN DIEGO, April 12, 2024 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN), a global...
Delta Air Lines (NYSE:DAL) – Delta Airlines reported a first-quarter profit of $37 million, a significant increase compared to the $363 million loss from the previous year. With adjusted...
Illumina appoints Ankur Dhingra Chief Financial Officer, Jakob Wedel Chief Strategy and Corporate Development Officer PR Newswire SAN DIEGO, April 9, 2024 Joydeep Goswami to serve as advisor...
Illumina to Announce First Quarter 2024 Financial Results on Thursday, May 2, 2024 PR Newswire SAN DIEGO, April 4, 2024 SAN DIEGO, April 4, 2024 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -14.14 | -10.7064435527 | 132.07 | 134.85 | 115.73 | 1546405 | 122.37121454 | CS |
4 | -22.78 | -16.1893255632 | 140.71 | 144.1899 | 115.73 | 1493572 | 129.29470303 | CS |
12 | -25.76 | -17.9274827754 | 143.69 | 148.19 | 115.73 | 1680314 | 135.60239147 | CS |
26 | -12.01 | -9.24272741265 | 129.94 | 148.19 | 89 | 2197661 | 122.77445625 | CS |
52 | -113.65 | -49.0759132913 | 231.58 | 232.23 | 89 | 1863872 | 145.50133092 | CS |
156 | -280.12 | -70.37306871 | 398.05 | 526 | 89 | 1368812 | 220.75395659 | CS |
260 | -203.84 | -63.3495975386 | 321.77 | 555.77 | 89 | 1275871 | 259.38677682 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions